Shanghai Institute OF Pharmaceutical Industry
USPTO PatentsView assignee record - 23 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Shanghai ranks #13,151 of 49,997 tracked US assignees by granted-patent volume, with 23 patents across 9 technology areas.
- #13,151
- of 49,997 US assignees by volume
- 36th percentile
- by Innovation Score (30.9/100)
- 11.9
- avg claims per patent
- -90%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13151 · Foreign Corporation #13,151 · 23 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 23 grants
- MID-PACK #13,151/49,997
- PHOTO-FINISH Sensory Incorporated
- CPC-NARROW A61P · 9 areas
- INNOV-THIN 30.9/100
- CLAIMS-PAR 11.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -90% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Sensory, Incorporated (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Shanghai’s 30.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Shanghai
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Shanghai Institute… · this assignee 31
Shanghai Institute… · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Shanghai's Innovation Score is 30.9/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Shanghai?
Each dot is one of Shanghai’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Shanghai’s own 11.9 claims/patent is at or below the 17.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Shanghai's grants concentrate
Shanghai Institute OF Pharmaceutical Industry is a focused PatentsView assignee: 9 CPC subclasses with 73.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2020. By volume, Shanghai sits between Sensory, Incorporated and Sirigen II Limited.
Shanghai's three-year grant acceleration
Shanghai Institute OF Pharmaceutical Industry shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Shanghai's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Sensory Incorpora…
Sensory, Incorporated
23 patents
- Sentinel Connecto…
Sentinel Connector Systems
23 patents
- Serta
Serta, Inc.
23 patents
- Shandong Yingxin…
Shandong Yingxin Computer Technologies Co., Ltd.
23 patents
- Shenzhen Kanger T…
Shenzhen Kanger Technology Co., Ltd
23 patents
- Shenzhen Yongchua…
Shenzhen Yongchuangcheng Technology Co., Ltd.
23 patents
- Shine
Shine Technologies, LLC
23 patents
- Sirigen II
Sirigen II Limited
23 patents
- Shanghai Institut… ◀
Shanghai Institute OF Pharmaceutical Industry
23 patents
What this shows Shanghai holds 23 patents at rank #13,139, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Shanghai
By rank, the assignees closest to #13,139 in granted patent volume.
- Sensory, Incorporated #13,135 · 23 patents
- Sentinel Connector Systems #13,136 · 23 patents
- Serta, Inc. #13,137 · 23 patents
- Shandong Yingxin Computer Technologies Co., Ltd. #13,138 · 23 patents
- Shenzhen Kanger Technology Co., Ltd #13,140 · 23 patents
- Shenzhen Yongchuangcheng Technology Co., Ltd. #13,141 · 23 patents
- Shine Technologies, LLC #13,142 · 23 patents
- Sirigen II Limited #13,143 · 23 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Shanghai's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Shanghai's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 36th percentile higher than 36% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 21.7% |
| 2016 | 6 | 26.1% |
| 2017 | 5 | 21.7% |
| 2018 | 2 | 8.7% |
| 2019 | 2 | 8.7% |
| 2020 | 1 | 4.3% |
| 2023 | 1 | 4.3% |
| 2025partial year | 1 | 4.3% |
Which technologies does Shanghai Institute OF Pharmaceutical Industry patent most?
Top 9 of 9 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Shanghai Institute OF Pharmaceutical Industry's patent record in context - here's where to go next.
- Shanghai Institute OF Pharmaceutical Industry's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 73.9% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #13,151 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Shanghai Institute OF Pharmaceutical Industry against Sensory, Incorporated, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.